Third Rock Ventures II, L.P. Insider Trading $GBT Global Blood Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Third Rock Ventures II, L.P..

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Third Rock Ventures II, L.P.. Third Rock Ventures II, L.P. is 10% Owner in MyoKardia Inc ($MYOK) and 10% Owner in Blueprint Medicines Corp ($BPMC) and 10% Owner in Sage Therapeutics, Inc. ($SAGE) and 10% Owner in Allena Pharmaceuticals, Inc. ($ALNA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Jounce Therapeutics, Inc. ($JNCE) and 10% Owner in Revolution Medicines, Inc. ($RVMD).

Third Rock Ventures II, L.P. in Global Blood Therapeutics, Inc.

Trading Symbol: GBT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Third Rock Ventures II, L.P.: 10% Owner
Holdings: 2,475,191 shares
Current Value: $40,098,094
Latest Transaction: Jun 16 2017
$GBT Market Capitalization: $626.91M
$GBT Previous Close: $16.20

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL

Last 3 Months Overview:
Buy: 0x
Sell: 14x
Shares Bought: 0
Shares Sold: 12,097,002
Share Difference: -12,097,002
Value Difference: +$90,965,476

Latest Insider Trading Transactions of Third Rock Ventures II, L.P. in Global Blood Therapeutics, Inc.

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, ALNA, BPMC, GBT, JNCE, MYOK, RVMD, SAGE

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 16 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,000,00002,475,1913.5 M to 2.5 M (-28.78 %)
May 19 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.001,000,00003,475,1914.5 M to 3.5 M (-22.35 %)
May 19 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerGiftG0.001,7080163,996165.7 K to 164 K (-1.03 %)
May 19 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerGiftG0.0050,0000165,704215.7 K to 165.7 K (-23.18 %)
Apr 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.002,000,00004,475,1916.5 M to 4.5 M (-30.89 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS28.7310,900313,146146,208157.1 K to 146.2 K (-6.94 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS27.697,279201,526157,108164.4 K to 157.1 K (-4.43 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS26.9527,115730,803164,387191.5 K to 164.4 K (-14.16 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS25.501,000,00025,500,000285,7131.3 M to 285.7 K (-77.78 %)
Mar 06 2017GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS25.501,000,00025,500,0006,475,1917.5 M to 6.5 M (-13.38 %)
Dec 16 2016GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.002,000,00007,475,1919.5 M to 7.5 M (-21.11 %)
Nov 16 2016GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS19.361,000,00019,360,0001,285,7132.3 M to 1.3 M (-43.75 %)
Nov 16 2016GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellS19.361,000,00019,360,0009,475,19110.5 M to 9.5 M (-9.55 %)
Nov 07 2016GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerSellJ0.002,000,000010,475,19112.5 M to 10.5 M (-16.03 %)
Aug 19 2015GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerOption ExerciseC0.0041,663,16800
Aug 19 2015GBTGlobal Blood Thera ...Third Rock Ventures II, L.P.10% OwnerBuyC0.0011,903,763012,475,191571.4 K to 12.5 M (+2,083.16 %)

Page:   1